Matches in SemOpenAlex for { <https://semopenalex.org/work/W2324179477> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2324179477 abstract "Triple negative (TN) breast cancers are defined by their lack of expression of hormone receptors and HER2 and account for approximately 15% of all breast cancers. They are highly aggressive tumors for which there is currently no effective targeted therapy. PTEN is a tumor suppressor gene that shows loss or mutation in many types of cancer. PTEN functions by deactivating Akt signaling so cell growth is inhibited and apoptosis is promoted. PTEN has also been found to have an important role in DNA repair. Cancers with PTEN loss have been shown to be sensitive to PARP inhibitors that prevent DNA repair and result in tumor cell death. In unselected breast cancer cohorts with the expected frequency of HER2 and hormone receptor positive cases, its loss appears to be a relatively rare event. Insulin-like growth factor binding protein-2 (IGFBP-2) regulates the anti-apoptotic and mitogenic effects of insulin like growth factors (IGF9s) -I and -II and can also exert its own intrinsic effects on cell function; in vitro cell line models have shown that IGFBP-2 down regulates PTEN expression by interacting with the β-integrin receptor. The purpose of the current study was to investigate the extent of PTEN loss in an Asian series of TN breast cancers also to determine the association of PTEN loss with IGFBP2 expression and clinicopathological features. 122 TN breast carcinomas from the University of Malaya Medical Centre were immunohistochemically (IHC) stained for CK5/6, CK14, PTEN and IGFBP-2. The basal-like phenotype was defined as positivity for either one or both of CK5/6 and CK14, in invasive tumour cells. A modified Allred scoring system was used to assess the IGFBP-2 staining. PTEN was assessed for loss in both the cytoplasm and the nuclei; the surrounding stromal tissue and normal ducts had to be positive for the case to be assessable. Expression of basal CKs were present in the majority of cases, with 72.5% and 70.4% of TN cases staining positively for CK5/6 and CK14, respectively. Loss of nuclear and cytoplasmic IHC staining for PTEN occurred in 44.9% of TN cases. In those cases with PTEN loss, 88.4% were positive for CK5/6 compared to only 66% for cases without PTEN loss. (p=0.011). The median age of patients with tumors showing PTEN loss were 48 years old, compared with 56 years in those without PTEN loss (p=0.007). Of the cases showing PTEN loss, 35/40 (87.5%) were Grade 3 tumors; in comparison 28/46 (60.9%) of tumors without PTEN loss were Grade 3 (p=0.008). With respect to IGFBP2, 26.5% of cases were positive using the cut-off score of 6 or greater. However, there was no significant association between PTEN loss and IGFBP2 expression (p= 0.542). Complete PTEN loss was a frequent event in a cohort of nearly one hundred TN breast cancers; this was significantly associated with younger age. PTEN loss can be readily and reliably assessed by an optimised IHC assay and validated PTEN antibody. The extent of PTEN loss occurring in TN breast cancers may well reflect a defect in DNA double strand repair and therefore, along with other suitable markers, may prove to be a valuable assay to identify those patients with TN breast cancers that are most likely to respond well to PARP inhibitors. Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P2-11-06." @default.
- W2324179477 created "2016-06-24" @default.
- W2324179477 creator A5005236363 @default.
- W2324179477 creator A5018593134 @default.
- W2324179477 creator A5026942968 @default.
- W2324179477 creator A5037287504 @default.
- W2324179477 creator A5037338885 @default.
- W2324179477 creator A5047315195 @default.
- W2324179477 creator A5062399385 @default.
- W2324179477 creator A5087872892 @default.
- W2324179477 date "2011-12-15" @default.
- W2324179477 modified "2023-09-27" @default.
- W2324179477 title "P2-11-06: PTEN Loss in Asian Triple Negative Breast Cancer Is a Frequent Event Associated with Basal Markers, Tumour Grade and Younger Age of Onset." @default.
- W2324179477 doi "https://doi.org/10.1158/0008-5472.sabcs11-p2-11-06" @default.
- W2324179477 hasPublicationYear "2011" @default.
- W2324179477 type Work @default.
- W2324179477 sameAs 2324179477 @default.
- W2324179477 citedByCount "0" @default.
- W2324179477 crossrefType "proceedings-article" @default.
- W2324179477 hasAuthorship W2324179477A5005236363 @default.
- W2324179477 hasAuthorship W2324179477A5018593134 @default.
- W2324179477 hasAuthorship W2324179477A5026942968 @default.
- W2324179477 hasAuthorship W2324179477A5037287504 @default.
- W2324179477 hasAuthorship W2324179477A5037338885 @default.
- W2324179477 hasAuthorship W2324179477A5047315195 @default.
- W2324179477 hasAuthorship W2324179477A5062399385 @default.
- W2324179477 hasAuthorship W2324179477A5087872892 @default.
- W2324179477 hasConcept C121608353 @default.
- W2324179477 hasConcept C126322002 @default.
- W2324179477 hasConcept C143998085 @default.
- W2324179477 hasConcept C190283241 @default.
- W2324179477 hasConcept C2777609662 @default.
- W2324179477 hasConcept C2778264664 @default.
- W2324179477 hasConcept C2780110267 @default.
- W2324179477 hasConcept C502942594 @default.
- W2324179477 hasConcept C530470458 @default.
- W2324179477 hasConcept C54355233 @default.
- W2324179477 hasConcept C555283112 @default.
- W2324179477 hasConcept C71924100 @default.
- W2324179477 hasConcept C86554907 @default.
- W2324179477 hasConcept C86803240 @default.
- W2324179477 hasConceptScore W2324179477C121608353 @default.
- W2324179477 hasConceptScore W2324179477C126322002 @default.
- W2324179477 hasConceptScore W2324179477C143998085 @default.
- W2324179477 hasConceptScore W2324179477C190283241 @default.
- W2324179477 hasConceptScore W2324179477C2777609662 @default.
- W2324179477 hasConceptScore W2324179477C2778264664 @default.
- W2324179477 hasConceptScore W2324179477C2780110267 @default.
- W2324179477 hasConceptScore W2324179477C502942594 @default.
- W2324179477 hasConceptScore W2324179477C530470458 @default.
- W2324179477 hasConceptScore W2324179477C54355233 @default.
- W2324179477 hasConceptScore W2324179477C555283112 @default.
- W2324179477 hasConceptScore W2324179477C71924100 @default.
- W2324179477 hasConceptScore W2324179477C86554907 @default.
- W2324179477 hasConceptScore W2324179477C86803240 @default.
- W2324179477 hasLocation W23241794771 @default.
- W2324179477 hasOpenAccess W2324179477 @default.
- W2324179477 hasPrimaryLocation W23241794771 @default.
- W2324179477 hasRelatedWork W1959453079 @default.
- W2324179477 hasRelatedWork W2022742795 @default.
- W2324179477 hasRelatedWork W2063084466 @default.
- W2324179477 hasRelatedWork W2064725509 @default.
- W2324179477 hasRelatedWork W2089116075 @default.
- W2324179477 hasRelatedWork W2118474643 @default.
- W2324179477 hasRelatedWork W2321614052 @default.
- W2324179477 hasRelatedWork W2333466320 @default.
- W2324179477 hasRelatedWork W2349831884 @default.
- W2324179477 hasRelatedWork W2353747883 @default.
- W2324179477 hasRelatedWork W2363067627 @default.
- W2324179477 hasRelatedWork W2380121124 @default.
- W2324179477 hasRelatedWork W2380600660 @default.
- W2324179477 hasRelatedWork W2394334799 @default.
- W2324179477 hasRelatedWork W2794612400 @default.
- W2324179477 hasRelatedWork W2899346905 @default.
- W2324179477 hasRelatedWork W2977105233 @default.
- W2324179477 hasRelatedWork W3014064455 @default.
- W2324179477 hasRelatedWork W342719612 @default.
- W2324179477 hasRelatedWork W63833860 @default.
- W2324179477 isParatext "false" @default.
- W2324179477 isRetracted "false" @default.
- W2324179477 magId "2324179477" @default.
- W2324179477 workType "article" @default.